355 related articles for article (PubMed ID: 31696361)
21. Rhabdomyosarcomas in adults and children: an update.
Parham DM; Ellison DA
Arch Pathol Lab Med; 2006 Oct; 130(10):1454-65. PubMed ID: 17090187
[TBL] [Abstract][Full Text] [Related]
22. Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
El Zein S; Djeroudi L; Reynaud S; Guillemot D; Masliah-Planchon J; Frouin E; Nicolas N; Le Loarer F; Daniel C; Delattre O; Pierron G; Watson S
Genes Chromosomes Cancer; 2022 Apr; 61(4):200-205. PubMed ID: 34877752
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of FOXO1 immunohistochemistry for rhabdomyosarcoma classification.
Rutland CD; Gedallovich J; Wang A; Zdravkovic S; Varma S; Hornick JL; Charville GW
Histopathology; 2023 Jul; 83(1):49-56. PubMed ID: 36860202
[TBL] [Abstract][Full Text] [Related]
24. Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma.
Croes R; Debiec-Rychter M; Cokelaere K; De Vos R; Hagemeijer A; Sciot R
Virchows Arch; 2005 Jan; 446(1):64-7. PubMed ID: 15660283
[TBL] [Abstract][Full Text] [Related]
25. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
[TBL] [Abstract][Full Text] [Related]
26. Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.
Chen S; Rudzinski ER; Arnold MA
Surg Pathol Clin; 2020 Dec; 13(4):729-738. PubMed ID: 33183730
[TBL] [Abstract][Full Text] [Related]
27. Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas.
De Chiara A; T'Ang A; Triche TJ
J Natl Cancer Inst; 1993 Jan; 85(2):152-7. PubMed ID: 8418305
[TBL] [Abstract][Full Text] [Related]
28. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract][Full Text] [Related]
29. Sclerosing rhabdomyosarcoma in childhood: case report and review of the literature.
Vadgama B; Sebire NJ; Malone M; Ramsay AD
Pediatr Dev Pathol; 2004; 7(4):391-6. PubMed ID: 15383934
[TBL] [Abstract][Full Text] [Related]
30. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract][Full Text] [Related]
31. Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.
Dashti NK; Wehrs RN; Thomas BC; Nair A; Davila J; Buckner JC; Martinez AP; Sukov WR; Halling KC; Howe BM; Folpe AL
Histopathology; 2018 Sep; 73(3):514-520. PubMed ID: 29758589
[TBL] [Abstract][Full Text] [Related]
32. Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens.
Montoya-Cerrillo DM; Diaz-Perez JA; Velez-Torres JM; Montgomery EA; Rosenberg AE
Genes Chromosomes Cancer; 2021 Oct; 60(10):687-694. PubMed ID: 34184341
[TBL] [Abstract][Full Text] [Related]
33. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
[TBL] [Abstract][Full Text] [Related]
34. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.
Parham DM
Mod Pathol; 2001 May; 14(5):506-14. PubMed ID: 11353062
[TBL] [Abstract][Full Text] [Related]
35. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.
Dias P; Parham DM; Shapiro DN; Webber BL; Houghton PJ
Am J Pathol; 1990 Dec; 137(6):1283-91. PubMed ID: 2260621
[TBL] [Abstract][Full Text] [Related]
36. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
[TBL] [Abstract][Full Text] [Related]
37. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
[No Abstract] [Full Text] [Related]
38. FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones.
Koutlas IG; Olson DR; Rawwas J
Head Neck Pathol; 2021 Mar; 15(1):374-380. PubMed ID: 32504289
[TBL] [Abstract][Full Text] [Related]
39. Update on Myogenic Sarcomas.
Agaram NP
Surg Pathol Clin; 2019 Mar; 12(1):51-62. PubMed ID: 30709448
[TBL] [Abstract][Full Text] [Related]
40. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].
Mentzel T
Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
